Cancer Discovery Senior Editor Tali Lev, PhD, is attending #SITC25. If you have a question about the journal or are interested in discussing your research, please reach out to her at avital.lev@aacr.org.

Join Tali Lev, PhD, Senior Editor, at AACR booth 707 from 9:30–10:30 AM on November 8th to learn about opportunities to publish in the journal. #SITC25

Attending #SITC25? Read this collection of articles that highlights recent advances in immuno-oncology, including identification of biomarkers of response to immunotherapies, neoantigen vaccine development, antibody therapies, and cellular therapies. https://t.co/A6hZaa6rDc

Cancer Discovery Senior Editor Tali Lev, PhD, is attending #SITC25 and would love to hear about your research. Connect with her to talk about publishing in the journal.

Stay tuned...Nominations will open soon for the Cancer Discovery Early Career Award!

Proposals for commentaries are due November 15 and can be sent to cancerdiscovery@aacr.org. Selected commentaries will be due in early January and will be published in the April 2026 issue of @CD_AACR. (2/2)

📢Exciting news! @CD_AACR is issuing another call for commentaries ahead of #AACR26! The meeting's theme is "Precision, Partnership, Purpose: Advancing Cancer Science to Save Lives Globally" - we want to hear YOUR ideas on how to achieve this goal. (1/2)

Reach out to @imsmd if you are at #CGCecDNA!

Now online in @CD_AACR: Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR-T cell Potency - by Laura Marcos-Kovandzic, @CBigenwald, Laurence Zitvogel, and colleagues https://t.co/YnSGlytP1Y @GustaveRoussy

The May issue is online. https://t.co/XAg7zPjzZV

The May issue of @CD_AACR is now online! The cover features work by Carlota Arenillas, @RToledoLab, et al. providing evidence of convergent genetic adaptation in hypoxic tumors and in high-altitude populations. Read this and much more here: https://t.co/roVI23XFfE @VHIO

Congratulations to @Sandra_Misale, PhD, recipient of the 2025 Cancer Discovery Early Career Award, which recognizes the outstanding contributions of #earlycareer investigators. Learn more: https://t.co/pBdtwVAKZu #AACR25 @HopkinsMedicine @hopkinskimmel @AACR

Online now concurrent with the #AACR25 Opening Plenary, by plenary speaker Catherine Wu: The Future of Personalized Cancer Vaccines https://t.co/6oOtXNfXa4

Online today concurrent with his #AACR25 award presentation!

HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Vaccine Efficacy https://t.co/s42u2de5pD By #AACR25 @Pezcoller–@AACR Award for Extraordinary Achievement in Cancer Research winner Douglas Hanahan

If you're at the #AACR25 Major Symposium on the Interplay between Immunology & Somatic Evolution, read the work in @CD_AACR being presented by speaker @ronny_drapkin on a precancer atlas of fallopian tube precursors to high-grade serous carcinoma https://t.co/gKIcfB0Uwr

Online now concurrent with the #AACR25 Major Symposium on Mechanisms Underlying Differences in Cancer Incidence, by speaker Jun Yu: Intrahepatic Microbial Heterogeneity in Multifocal HCC and Its Association with Host Genomic and Transcriptomic Alterations https://t.co/hb7L8CRIar

Online now for the #AACR25 Late-Breaking Abstract Minisymposium: Mutant p53 Gain of Function: Why Many See It, Why some Don’t https://t.co/PttlPshrCS A perspective by @drgglozano, Carol Prives, and Kanaga Sabapathy

Online now concurrent with the #AACR25 Major Symposium on #Immunometabolism by session speaker @PCHo_Lab: PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Anti-Tumor Immunity against Liver Cancer and Liver Metastasis https://t.co/uhNiPukCX1

Online now concurrent with the #AACR25 oral presentation by Cancer Discovery Early Career Award Winner @Sandra_Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations https://t.co/0hwAJj17rF